Načítá se...
Development of pyoderma gangrenosum during therapy with infliximab
BACKGROUND: Pyoderma gangrenosum is a rare inflammatory disease of unknown etiology and a poorly understood pathogenesis. Its clinical presentation is variable and a large percentage of cases are associated with inflammatory bowel diseases. Peristomal pyoderma gangrenosum represents a variant of the...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Specjalisci Dermatolodzy
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3157791/ https://ncbi.nlm.nih.gov/pubmed/21886723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3315/jdcr.2009.1027 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|